SILVESTRI, Carmela
 Distribuzione geografica
Continente #
NA - Nord America 2.786
EU - Europa 1.271
AS - Asia 1.111
SA - Sud America 227
AF - Africa 51
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.451
Nazione #
US - Stati Uniti d'America 2.751
SG - Singapore 343
UA - Ucraina 236
VN - Vietnam 206
CN - Cina 198
RU - Federazione Russa 198
BR - Brasile 157
IT - Italia 152
TR - Turchia 126
IE - Irlanda 122
SE - Svezia 122
DE - Germania 121
FR - Francia 92
DK - Danimarca 86
HK - Hong Kong 69
FI - Finlandia 63
KR - Corea 49
CI - Costa d'Avorio 36
AR - Argentina 31
GB - Regno Unito 31
IN - India 25
BD - Bangladesh 20
CA - Canada 18
EC - Ecuador 10
IQ - Iraq 10
JP - Giappone 10
NL - Olanda 9
RO - Romania 9
MX - Messico 8
VE - Venezuela 8
ES - Italia 7
ZA - Sudafrica 7
CO - Colombia 6
ID - Indonesia 6
PK - Pakistan 6
PL - Polonia 6
UZ - Uzbekistan 6
KZ - Kazakistan 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
MY - Malesia 4
OM - Oman 4
PE - Perù 4
JO - Giordania 3
MA - Marocco 3
PH - Filippine 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
CY - Cipro 2
PS - Palestinian Territory 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BS - Bahamas 1
CG - Congo 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
KH - Cambogia 1
KI - Kiribati 1
LT - Lituania 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
SA - Arabia Saudita 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TO - Tonga 1
WS - Samoa 1
Totale 5.451
Città #
Ashburn 479
Jacksonville 228
Chandler 224
Fairfield 208
Singapore 198
Dallas 171
San Jose 142
Dublin 122
Wilmington 107
Boardman 99
Woodbridge 91
Houston 80
Cambridge 76
Ho Chi Minh City 74
Seattle 72
Hong Kong 66
New York 64
Beijing 50
Hanoi 49
Lawrence 46
Princeton 46
San Mateo 44
Moscow 43
Lauterbourg 40
Los Angeles 39
Abidjan 36
Turin 36
Ann Arbor 35
Hefei 31
The Dalles 30
Buffalo 24
Munich 19
Milan 18
São Paulo 18
San Diego 17
Orem 14
Council Bluffs 12
Des Moines 12
Montreal 12
Denver 11
Turku 11
Da Nang 10
Chicago 8
London 8
Phoenix 8
Chennai 7
Helsinki 7
Izmir 7
Norwalk 7
Porto 7
Santa Clara 7
Stockholm 7
Brooklyn 6
Centro 6
Miano 6
Nuremberg 6
Tashkent 6
Tokyo 6
Amsterdam 5
Atlanta 5
Guayaquil 5
Haiphong 5
Johannesburg 5
Warsaw 5
Caracas 4
Guangzhou 4
Manchester 4
New Delhi 4
Poplar 4
Pune 4
Ribeirão Preto 4
Rio de Janeiro 4
Shanghai 4
Wuhan 4
Wuxi 4
Bauru 3
Belgrade 3
Boston 3
Bắc Ninh 3
Can Tho 3
Delhi 3
Dhaka 3
Guarulhos 3
Hải Dương 3
Indaiatuba 3
Kilburn 3
Mumbai 3
Muscat 3
Nha Trang 3
North Bergen 3
Osaka 3
Quito 3
Rome 3
Salt Lake City 3
Toronto 3
Amman 2
Ankara 2
Baghdad 2
Belo Horizonte 2
Berazategui 2
Totale 3.457
Nome #
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 157
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 154
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 148
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 144
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 141
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 139
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 138
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 132
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 132
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 132
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 131
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 131
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 131
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 130
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 127
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 126
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 125
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 124
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 123
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. 122
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 122
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 120
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 119
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 118
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 117
Urinary catheters and biofilm formation 117
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. 115
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 115
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 115
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. 114
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 113
Quorum Sensing Inhibitor FS3-coated Vascular Graft Enhances Daptomycin Efficacy in a Rat Model of Staphylococcal Biofilm Infection. 113
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 110
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 109
In vitro activities of tachyplesin III against Pseudomonas aeruginosa. 107
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 106
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes. 105
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 105
Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation 105
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci. 100
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 99
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 98
Prevalence of intestinal parasites among individuals with allergic skin diseases. 97
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 97
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 94
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 87
Totale 5.504
Categoria #
all - tutte 25.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 0 0 33
2021/2022365 34 76 2 3 4 37 22 14 21 62 17 73
2022/2023647 58 97 52 43 41 65 2 31 160 4 75 19
2023/2024326 66 8 19 56 62 63 5 5 0 2 3 37
2024/2025648 98 49 34 6 40 32 57 23 127 18 88 76
2025/20262.011 144 185 141 192 209 121 347 198 201 167 24 82
Totale 5.504